Proteins at the intersection of circadian rhythms and metabolic dysfunction-associated steatotic liver disease: an 18-protein panel as a novel predictive biomarker set - Summary - MDSpire

Proteins at the intersection of circadian rhythms and metabolic dysfunction-associated steatotic liver disease: an 18-protein panel as a novel predictive biomarker set

  • By

  • Yiyi Wang

  • Qilong Zhai

  • Xuemei Lian

  • Lei Zhao

  • May 13, 2026

Share

Objective:

To explore the relationship between circadian rhythm disruption and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and identify potential protein biomarkers for predicting MASLD risk, which could enhance early detection and treatment strategies.

Key Findings:
  • Lower RA was significantly associated with a higher prevalence of MASLD (crude OR = 2.61; 95% CI [2.42, 2.81]; adjusted OR = 1.15; 95% CI [1.02, 1.31]).
  • Eighteen candidate proteins were identified as potential biomarkers for RA-related MASLD.
  • The 18-protein model demonstrated high predictive capability with AUC values exceeding 0.94 across various machine learning techniques.
Interpretation:

The study confirms that lower RA is independently linked to MASLD and highlights 18 overlapping plasma proteins as promising biomarkers for predicting RA-related MASLD, suggesting avenues for future research and clinical applications.

Limitations:
  • The study relies on observational data, which may limit causal inferences.
  • Potential confounding factors not accounted for in the analysis could affect results.
  • Findings may not be generalizable beyond the UK Biobank population.
Conclusion:

The findings suggest that monitoring circadian rhythm through RA and the identified protein biomarkers could provide new avenues for predicting and potentially treating MASLD.

Original Source(s)

Proteins at the intersection of circadian rhythms and metabolic dysfunction-associated steatotic liver disease: an 18-protein panel as a novel predictive biomarker set

  • by Yiyi Wang, Qilong Zhai, Xuemei Lian, Lei Zhao

  • May 13, 2026

Related Content

COA and Flatiron Health Study Finds Patients May Experience Longer Survival in Community Oncology Settings

Patients diagnosed with metastatic breast cancer and non–small cell lung cancer had longer survival compared to national benchmarks when treated in independent community oncology practices, according ...

Early-Onset Lung Cancer May Be Connected to Pesticide Contaminants

Dietary patterns in young patients with lung cancer suggest that many have higher dietary quality scores than average U.S. reference values, according to results from a study presented at the American...

Unique Phase I NSCLC Trial Sites Decreasing in United States

The number of unique clinical trial sites in the United States with phase I studies for patients with non–small cell lung cancer (NSCLC) decreased by 44% from 2020 to 2024, showing a significant conso...